E. W. Lamon
Karolinska Institutet
12 Papers
521 Citations
E. W. Lamon is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Antigen & Moloney Sarcoma Virus. The author has an hindex of 10, co-authored 12 publications.
Chat about Author
Papers
The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.
TL;DR: Data demonstrate specific T cell and non-T cell activity in microcytotoxicity tests with a tumor-specific system and strongly suggest that the non- T cell activity described herein is a B cell function.
In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen
TL;DR: With the development of methods for isolation of Bor T cell-deficient populations it has been possible to delineate the functions of these cells and some of their interrelationships.
Synergistic or antagonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the moloney sarcoma virus system
TL;DR: Under different experimental conditions, pretreatment of target cells with humoral antibody may protect them from the cytotoxic effect of immune lymphocytes or mediate their destruction by a normal lymphocyte population; in vivo probably a balance between these two phenomena occurs.
•Journal Article
Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
TL;DR: In this paper, antisera with specificity for Moloney leukemia virus (MLV) determined antigen(s) were studied for their ability to induce MLV antigen bearing target cell reduction by lymphocytes in microcytotoxicity assays.
79
•Journal Article
IgM complex receptors on subpopulations of murine lymphocytes.
TL;DR: Lymphocytes from all three organs were found to bind SRBC sensitized with IgM from various sources including: primary anti-SRBC serum, murine and rabbit anti-Escherichia coli LPS sera, and a murine IgM myeloma (MOPC 104E).
60